SEC Filing Summary: BioSig Technologies, Inc. (BSGM)
Business Context and Reporting Period
This Form 8-K Current Report was filed by BioSig Technologies, Inc. on February 17, 2023. The registrant is incorporated in Delaware and trades on the NASDAQ Capital Market under the symbol BSGM. The report discloses a material event regarding intellectual property rather than a standard financial reporting period.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report focused on a specific corporate event and does not contain financial statements or performance metrics.
Material Changes
The primary material change disclosed is the issuance of a utility patent by the United States Patent Office. The patent covers the Company's Pure EP universal notch filtering technology. This represents a significant milestone in the Company's intellectual property portfolio.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, financial outlook, or specific risk factors related to the patent issuance. Management commentary is limited to the announcement of the patent grant. The Company explicitly states it undertakes no obligation to update, supplement, or amend the materials attached to this report. Additionally, the information is furnished under Regulation FD but is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the specific scope and claims of the newly issued utility patent for Pure EP technology.
- Confirm the commercialization timeline and potential revenue impact of the patented technology.
- Review the attached press release (Exhibit 99.1) for additional technical details not included in the summary.
- Check subsequent filings for any updates on the patent's status or related litigation.